OpenAI's board chairman on Friday said it has unanimously rejected an Elon Musk-led offer to buy the hot artificial ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
The era of ultralow interest rates fostered a leveraged buyout boom and a desperate hunger for yield among investors. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results